share_log

Lineage Cell Therapeutics Q1 EPS $(0.03) Vs. $(0.04) Prior Year, Sales $2.39M Beat $2.01M Estimate

Lineage Cell Therapeutics Q1 EPS $(0.03) Vs. $(0.04) Prior Year, Sales $2.39M Beat $2.01M Estimate

Lineage Cell Therapeutics第一季度每股收益为0.03美元,去年同期为0.04美元,销售额为239万美元,超过预期的201万美元
Benzinga ·  2023/05/12 04:12

Lineage Cell Therapeutics (AMEX:LCTX) reported quarterly losses of $(0.03) per share. This is a 25 percent increase over losses of $(0.04) per share from the same period last year. The company reported quarterly sales of $2.39 million which beat the analyst consensus estimate of $2.01 million by 18.71 percent. This is a 54.44 percent decrease over sales of $5.24 million the same period last year.

Lineage Cell Therapeutics(AMEX: LCTX)公布的季度每股亏损为0.03美元。与去年同期相比,每股亏损0.04美元,增长了25%。该公司公布的季度销售额为239万美元,比分析师共识估计的201万美元高出18.71%。这比去年同期的524万美元销售额下降了54.44%。

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发